Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes.

So Young ParkJi Eun Jun In-Kyung JeongKyu Jeung AhnHo Yeon ChungYou Cheol Hwang

Published in: The Journal of clinical endocrinology and metabolism (2024)

Adding ezetimibe to a moderate-intensity statin in patients with type 2 diabetes has a greater LDL-C-lowering effect and greater primary prevention of composite outcomes than that of high-intensity statin monotherapy.

Keyphrases

high intensity
combination therapy
cardiovascular disease
type diabetes
low density lipoprotein
coronary artery disease
resistance training
glycemic control
clinical trial
insulin resistance
metabolic syndrome
adipose tissue
skeletal muscle
body composition
weight loss